Xingnan Pan

Quanzhou, 362100, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

A non-invasive diagnostic nomogram for CHB-related early cirrhosis: a prospective study.

A non-invasive diagnostic nomogram for CHB-related early cirrhosis: a prospective study.

Journal: Scientific reports
Published: November 12, 2023

Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.

Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.

Journal: European radiology
Published: September 23, 2021

Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Journal: Liver cancer
Published: June 25, 2019

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT.

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT.

Journal: Scientific reports
Published: August 22, 2018

Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study.

Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study.

Journal: Journal of hepatology
Published: June 16, 2018

Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.

Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.

Journal: Journal of medical virology
Published: June 08, 2017

Genome-wide association study identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure.

Genome-wide association study identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure.

Journal: Gut
Published: September 12, 2016

Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.

Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.

Journal: Medicine
Published: March 28, 2015

Huge hepatic angiosarcoma with spine, pelvis, spleen and pulmonary metastases: a case report

Huge hepatic angiosarcoma with spine, pelvis, spleen and pulmonary metastases: a case report

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: September 10, 2014

Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.

Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.

Journal: Oncology letters
Published: June 21, 2014

Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B.

Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B.

Journal: Molecular medicine reports
Published: February 28, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026